Clinical trial

SPECT/CT Imaging for Dosimetry in 177Lu-PSMA-617 (Pluvicto) Therapy

NCT07096999

StatusRECRUITING

Study typeOBSERVATIONAL

Start date2025-01-23

PhaseN/A

Study timeline

Study start (actual)2025-01-23Date precision: day

Registry last updated2026-07-27

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Metastatic Castration-Resistant Prostate Carcinomaunresolved

Interventions

Non-Interventional StudyOTHER

Sponsors & collaborators

University of Michigan Rogel Cancer Centerlead sponsor

National Cancer Institute (NCI)collaborator

Mapped research locations

Ann ArborMichigan, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07096999 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.